REGENLIFE
REGEnLIFE develops a cutting-edge photomedical neurotechnology for the treatment of neurodegenerative diseases. REGEnLIFE is a late-stage medical technology company currently focused on the treatment of Alzheimer's disease and mild traumatic brain injury (which can lead to dementia). The medical device is a patented therapeutic solution based on biophotonics. This non-invasive and painless application targets both the brain and the gut. Recent scientific studies suggest that the brain-gut axis plays a key role in the development of neurodegenerative diseases.
REGENLIFE
Industry:
Health Care Life Science Medical Device Neuroscience
Founded:
2016-01-19
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.regenlife.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Sitelinks Search Box Amazon Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins WPBakery Amazon SSL
Similar Organizations
JPND Research
Joint Programme – Neurodegenerative Disease Research
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Suisse Forme
Med-tech company primarily focused on manufacturing dental aligners
Vamstar
GenAI-powered Global B2B Healthcare Marketplace
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Walden Biosciences
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Current Employees Featured
Founder
Official Site Inspections
http://www.regenlife.com
- Host name: server-3-167-37-71.iad61.r.cloudfront.net
- IP address: 3.167.37.71
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "REGEnLIFE"
REGEnLIFE website
Nov 26, 2021 · REGEnLIFE se donne pour mission de développer des technologies innovantes et responsables, répondant à des enjeux sociétaux et de santé publique.See details»
REGEnLIFE - Crunchbase Company Profile & Funding
REGEnLIFE develops a cutting-edge photomedical neurotechnology for the treatment of neurodegenerative diseases. REGEnLIFE is a late-stage medical technology company …See details»
REGEnLIFE website
REGEnLIFE est une société de technologies médicales à un stade clinique avancé et positionnée sur le traitement des affections neurologiques. Elle développe une solution thérapeutique …See details»
REGEnLIFE - LinkedIn
Neurotech & photomedicine | REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical …See details»
Company portrait | REGEnLIFE - Eurobiomed
Apr 19, 2024 · REGEnLIFE is a medtech based in Montpellier at an advanced clinical stage and positioned on the treatment of neurodegenerative diseases. It is developing a patented …See details»
REGEnLIFE Company Profile 2024: Valuation, Funding & Investors
REGEnLIFE was founded in 2016. Where is REGEnLIFE headquartered? REGEnLIFE is headquartered in Paris, France. What is the size of REGEnLIFE? REGEnLIFE has 3 total …See details»
REGEnLIFE - Products, Competitors, Financials, Employees, …
REGEnLIFE is a clinical-stage medical technology company that focuses on the treatment of neurodegenerative diseases specifically Alzheimer-type dementia. It develops a patented …See details»
REGEnLIFE website
Le dispositif RGn développé par REGEnLIFE est actuellement la seule technologie photomédicale à prendre en compte les hypothèses émergentes sur l’identification des …See details»
ReGEN Life
Aging can be defeated within our lifetimes. We take a bold approach to anti-aging and life extension — harnessing biology to overcome the world’s most formidable challenge. ReGEN …See details»
REGEnLIFE - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time?See details»
REGEnLIFE - Eurobiomed
REGEnLIFE is a late-stage medical technology company focused on the treatment of neurodegenerative diseases. It is developing a patented therapeutic solution based on …See details»
About - ReGEN Life
With our deep expertise in gene editing, controlling gene expression, and epigenetics, we are uniquely positioned to use our innovative science to defeat aging within our lifetimes. ReGEN …See details»
Portrait d'entreprise | REGEnLIFE - Eurobiomed
Apr 19, 2024 · REGEnLIFE est une medtech basée à Montpellier à un stade clinique avancé et positionnée sur le traitement des maladies neurodégénératives. Elle développe une solution …See details»
REGEnLIFE website
S’inscrivant dans le secteur des neurotechnologies et de la photomédecine, REGEnLIFE développe un traitement innovant avec une action à la fois préventive et curative : la …See details»
Nancy Anderberg - CEO REGENLife - Anti-Aging Regenerative …
Developing international sales organizations and event trainer as an elite independent distributor for Lifevantage; a publicly held company listed as LFVN on Nasdaq. My personal organization...See details»
REGEnLIFE presents first results of pilot clinical trial evaluating ...
Mar 17, 2021 · REGEnLIFE’s innovative non-invasive technology, evaluated in a therapeutic trial, is based on photobiomodulation, targeting both the brain and gut via a helmet and abdominal …See details»
REGEnLIFE Is Trying to Prove That Advanced Light Therapy Can …
Oct 31, 2024 · A team of scientists in France is working on a promising clinical trial that uses photobiomodulation (a form of light therapy) to reduce inflammation in the brain and the gut …See details»
REGEnLIFE’s trial of photobiomodulation technology for …
Mar 30, 2021 · REGEnLIFE’s innovative non-invasive technology is based on photobiomodulation, targeting both the brain and gut via a helmet and abdominal device. This …See details»
REGEnLIFE presents first results of pilot clinical trial evaluating ...
REGEnLIFE, a french company specialized in the research and development of innovative photo-medical technologies for the prevention and treatment of neurodegenerative diseases, …See details»
Regenlife gets $3.3M to develop photobiomodulation for ...
May 19, 2023 · Regenlife SAS raised $3.3 million in series A funding in order to finalize the development of its photomodulation technology to treat neurodegenerative diseases.See details»